Literature DB >> 1511324

Lewy bodies contain beta-amyloid precursor proteins of Alzheimer's disease.

H Arai1, V M Lee, W D Hill, B D Greenberg, J Q Trojanowski.   

Abstract

To assess the contribution of Alzheimer's disease amyloid proteins to cortical and substantia nigra Lewy bodies (LBs), regions of postmortem brain rich in intraneuronal LBs were examined immunohistochemically. Antibodies to epitopes in domains outside the amyloidogenic beta-amyloid peptide (BAP) in BAP precursor proteins (BAPPs) as well as to the BAP itself were used as probes. These studies showed that only BAPP epitopes outside the BAP were present in substantia nigral and cortical LBs. Thus, non-amyloidogenic domains of BAPPs may be associated with intraneuronal inclusions comprised of neurofilament proteins.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1511324     DOI: 10.1016/0006-8993(92)91242-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

Review 1.  The Lewy body in Parkinson's disease and related neurodegenerative disorders.

Authors:  Koichi Wakabayashi; Kunikazu Tanji; Saori Odagiri; Yasuo Miki; Fumiaki Mori; Hitoshi Takahashi
Journal:  Mol Neurobiol       Date:  2012-05-24       Impact factor: 5.590

2.  Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders.

Authors:  A Takeda; M Mallory; M Sundsmo; W Honer; L Hansen; E Masliah
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

Review 3.  Probing modifications of the neuronal cytoskeleton.

Authors:  L C Doering
Journal:  Mol Neurobiol       Date:  1993 Fall-Winter       Impact factor: 5.590

4.  Immunoreactivity profile of hippocampal CA2/3 neurites in diffuse Lewy body disease.

Authors:  D W Dickson; M L Schmidt; V M Lee; M L Zhao; S H Yen; J Q Trojanowski
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

5.  Microglial MAC1 receptor and PI3K are essential in mediating β-amyloid peptide-induced microglial activation and subsequent neurotoxicity.

Authors:  Dan Zhang; Xiaoming Hu; Li Qian; Shih-Heng Chen; Hui Zhou; Belinda Wilson; David S Miller; Jau-Shyong Hong
Journal:  J Neuroinflammation       Date:  2011-01-13       Impact factor: 8.322

Review 6.  Metabolic Abnormalities of Erythrocytes as a Risk Factor for Alzheimer's Disease.

Authors:  Elena A Kosenko; Lyudmila A Tikhonova; Carmina Montoliu; George E Barreto; Gjumrakch Aliev; Yury G Kaminsky
Journal:  Front Neurosci       Date:  2018-01-05       Impact factor: 4.677

Review 7.  Importance of adiponectin activity in the pathogenesis of Alzheimer's disease.

Authors:  Masaaki Waragai; Gilbert Ho; Yoshiki Takamatsu; Kazunari Sekiyama; Shuei Sugama; Takato Takenouchi; Eliezer Masliah; Makoto Hashimoto
Journal:  Ann Clin Transl Neurol       Date:  2017-07-11       Impact factor: 4.511

Review 8.  The Erythrocytic Hypothesis of Brain Energy Crisis in Sporadic Alzheimer Disease: Possible Consequences and Supporting Evidence.

Authors:  Elena Kosenko; Lyudmila Tikhonova; Gubidat Alilova; Amparo Urios; Carmina Montoliu
Journal:  J Clin Med       Date:  2020-01-12       Impact factor: 4.241

9.  Antagonistic roles for Ataxin-2 structured and disordered domains in RNP condensation.

Authors:  Amanjot Singh; Joern Hulsmeier; Arvind Reddy Kandi; Sai Shruti Pothapragada; Jens Hillebrand; Arnas Petrauskas; Khushboo Agrawal; Krishnan Rt; Devasena Thiagarajan; Deepa Jayaprakashappa; K VijayRaghavan; Mani Ramaswami; Baskar Bakthavachalu
Journal:  Elife       Date:  2021-03-10       Impact factor: 8.140

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.